National Australia Bank (NAB) Chief Financial Officer Nathan Goonan will depart later this year to take on the same role at rival Westpac, the banks confirmed on Monday.
Goonan, who became NAB’s CFO in July 2023, previously led the group’s strategy and development. During his tenure, NAB’s stock surged approximately 26% from July 1, 2023, to its last close on Friday.
NAB announced Goonan’s exit alongside other senior executive changes. Following this, Westpac disclosed his appointment, with current CFO Michael Rowland set to remain in his position until Goonan’s transition.
Shares of Westpac gained 0.7%, while NAB’s stock dipped 0.4% as of 0005 GMT.
This move comes amid ongoing leadership shifts at both banks. In December, Rowland announced plans to retire in 2025. Last month, NAB appointed Andrew Irvine, head of business and private banking, as its new CEO. Westpac promoted Anthony Miller, formerly head of business and wealth, to CEO in September.
Market experts view these transitions as part of broader strategic realignments. Senior analyst Henry Jennings noted that Irvine’s appointment was expected to bring leadership changes, while Westpac’s new CEO likely influenced Goonan’s hiring.
Until NAB appoints a permanent successor, Group Chief Risk Officer Shaun Dooley will serve as interim CFO.
The leadership shuffle underscores Australia’s competitive banking landscape, with major lenders repositioning executives to strengthen their market standing.


SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Apple Turns 50: From Garage Startup to AI Crossroads
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 



